Constellium (NYSE:CSTM) Stock Rating Raised to Overweight at JPMorgan Chase & Co.

Key Points

• JPMorgan upgraded Constellium to “overweight” from “neutral” and set a $35 price target, implying 43.9% upside from the prior close. The stock carries a consensus “Moderate Buy” rating with an average target of $33.71.
• Constellium reported quarterly EPS of $0.84, beating the $0.73 consensus, while revenue rose 21.8% year over year to $2.64 billion, above expectations.
• Despite stronger results and increased institutional ownership, investors face risks from cyclical demand, high leverage, declining shipments and rising input costs that could pressure future margins and growth.

Constellium (NYSE:CSTM - Get Free Report) was upgraded by stock analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a report released on Thursday, MarketBeat.com reports. The brokerage currently has a $35.00 target price on the industrial products company's stock. JPMorgan Chase & Co.'s price objective points to a potential upside of 43.90% from the stock's previous close.

Several other equities analysts also recently weighed in on CSTM. Barclays began coverage on shares of Constellium in a research note on Wednesday, October 14th. They issued an "equal weight" rating and a $28.00 price target on the stock. Wells Fargo & Company cut their price objective on shares of Constellium from $39.00 to $38.00 and set an "overweight" rating for the company in a report on Friday, September 18th. HSBC set a $35.00 target price on shares of Constellium in a research note on Thursday. UBS Group lowered their target price on Constellium from $34.00 to $32.00 and set a "buy" rating on the stock in a report on Thursday, October 8th. Finally, Zacks Research lowered Constellium from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 6th. Five equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $33.71.

Constellium Stock Performance

NYSE CSTM opened at $24.32 on Thursday. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.43 and a quick ratio of 0.61. The stock's 50 day simple moving average is $25.67 and its 200-day simple moving average is $27.82. The company has a market cap of $3.30 billion, a PE ratio of 6.27 and a beta of 1.57. Constellium has a 1-year low of $14.62 and a 1-year high of $36.99.

Constellium (NYSE:CSTM - Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The industrial products company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.73 by $0.11. Constellium had a return on equity of 51.66% and a net margin of 5.69%. The firm had revenue of $2.64 billion during the quarter, compared to the consensus estimate of $2.50 billion. During the same period in the prior year, the company earned $0.62 EPS. The firm's revenue was up 21.8% compared to the same quarter last year. As a group, equities research analysts anticipate that Constellium will post 3.79 EPS for the current fiscal year.

Insider Activity

In other news, Director Jean-Christophe Deslarzes acquired 1,490 shares of the business's stock in a transaction that occurred on Monday, August 3rd. The stock was purchased at an average cost of $27.24 per share, for a total transaction of $40,587.60. Following the completion of the transaction, the director owned 43,515 shares in the company, valued at approximately $1,185,348.60. This trade represents a 3.55% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.20% of the company's stock.

Hedge Funds Weigh In On Constellium

Institutional investors and hedge funds have recently bought and sold shares of the company. Arrowstreet Capital Limited Partnership grew its stake in shares of Constellium by 620.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company's stock valued at $79,345,000 after buying an additional 2,780,260 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Constellium by 894.4% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,056,336 shares of the industrial products company's stock valued at $50,545,000 after acquiring an additional 1,849,554 shares during the last quarter. Bank of America Corp DE lifted its holdings in Constellium by 100.1% in the first quarter. Bank of America Corp DE now owns 851,222 shares of the industrial products company's stock valued at $20,923,000 after acquiring an additional 425,871 shares during the last quarter. Janus Henderson Group PLC grew its position in Constellium by 775.9% in the first quarter. Janus Henderson Group PLC now owns 439,301 shares of the industrial products company's stock worth $10,797,000 after acquiring an additional 389,147 shares during the period. Finally, Hillsdale Investment Management Inc. purchased a new position in Constellium in the first quarter worth approximately $7,784,000. 92.59% of the stock is currently owned by institutional investors and hedge funds.

More Constellium News

Here are the key news stories impacting Constellium this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.84 per share, above estimates of approximately $0.73–$0.74 and up from $0.62 a year earlier. Revenue rose 21.8% year over year to $2.64 billion, exceeding the $2.50 billion consensus estimate. Constellium Beats Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management raised its full-year 2026 guidance, providing investors with increased confidence that demand, operating execution and cost discipline can support continued earnings growth. Strong packaging and aerospace demand were identified as key contributors. Constellium Reports Strong Third Quarter 2026 Results; Raises Full Year 2026 Guidance
• Neutral Sentiment: The results reinforce Constellium’s improving financial performance, including substantial revenue growth and year-over-year EPS expansion. However, the company remains exposed to cyclical metal demand, input-cost changes and relatively high leverage, which may keep the shares volatile.
• Negative Sentiment: Some coverage highlighted declining shipments and guidance commentary suggesting slower future growth. Those concerns may be offsetting the earnings beat and guidance increase, as investors focus on whether recent revenue momentum can continue. Constellium shares fall as shipments decline, outlook signals slower growth
• Negative Sentiment: Rising input costs remain a risk to margins, particularly if Constellium cannot fully pass higher costs on to customers. This could limit the benefit of strong sales growth in upcoming quarters.

Constellium Company Profile

Constellium SE NYSE: CSTM is a global manufacturer of aluminum products and components. The company develops and produces rolled, extruded and formed aluminum solutions for customers in the aerospace, automotive, packaging, transportation and industrial sectors.

Its products include aerospace plates and sheets, automotive body and structural components, aluminum beverage-can sheet, foil stock, extrusions and other engineered components. Constellium's offerings are used in aircraft structures, vehicles, beverage and food packaging, rail transportation and various industrial applications.

Constellium was established in 2011 following the acquisition and combination of aluminum products businesses formerly associated with Alcan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.